Antiseptic-Coated Sutures and Pancreatic Fistula Risk After Pancreatoduodenectomy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Cleveland Clinic

About this trial

The purpose of this study is to determine if the use of antiseptic-coated sutures is better than the use of the standard sutures in preventing postoperative fistulas within 90 days after pancreatoduodenectomy.

Eligibility criteria

Qualifiers

Subjects must be undergoing a scheduled pancreatoduodenectomy.

Age ≥18 years.

Subjects must have the ability to understand and the willingness to sign a written informed consent document

Disqualifiers

Patients < 18 years old

Patients who are pregnant

Patients with history of previous pancreatic surgery

Patients who are unable to provide informed consent

Trial design

Treatments tested in this trial

  • Standard (non-antiseptic coated) suture will be used.
  • Triclosan/antiseptic -coated suture

Treatment groups

436 Participants
are divided into 2 treatment groups

Sponsors and collaborators

The Cleveland Clinic

Lead sponsor

Ethicon, Inc.

Collaborator